Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab for trigeminal neuralgia
2019-000848-95Phase 2Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in trigeminal neuralgia (TN) comparing Erenumab with Placebo (2 arms). Primary endpoint: Responder rate during evaluation period. Started Feb 2019; status: completed.
02
Drugs
erenumab
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2019-000848-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000848-95.